Krystyna Pawlak

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Biomedicines

Journal of clinical medicine

Cancers

International journal of molecular sciences

Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University Oct 01 2012

Poland

head of Department/professor :: Monitored Pharmacotherapy

Publications

Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Anna Krupa, Mikolaj M Krupa, Krystyna Pawlak
Indoleamine 2,3 Dioxygenase 1-The Potential Link between the Innate Immunity and the Ischemia-Reperfusion-Induced Acute Kidney Injury? International journal of molecular sciences 23 (11) (2022)
Anna Krupa, Mikolaj M Krupa, Krystyna Pawlak
Kynurenine Pathway-An Underestimated Factor Modulating Innate Immunity in Sepsis-Induced Acute Kidney Injury? Cells 11 (16) (2022)
Marta Ziemińska, Dariusz Pawlak, Beata Sieklucka, Katarzyna Chilkiewicz, Krystyna Pawlak
Vitamin K-Dependent Carboxylation of Osteocalcin in Bone-Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease? Nutrients 14 (19) (2022)
Marta Ziemińska, Beata Sieklucka, Krystyna Pawlak
Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together? Nutrients 13 (3) (2021)
Justyna Magdalena Hermanowicz, Krystyna Pawlak, Beata Sieklucka, Robert Czarnomysy, Iwona Kwiatkowska, Adam Kazberuk, Arkadiusz Surazynski, Mariusz Mojzych, Dariusz Pawlak
MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer. Cancers 13 (13) (2021)
Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak
Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer. Pharmaceutics 13 (8) (2021)
Krystyna Pawlak, Beata Sieklucka, Dariusz Pawlak
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling. International journal of molecular sciences 22 (12) (2021)
Adrian Mor, Krystyna Pawlak, Bartlomiej Kalaska, Tomasz Domaniewski, Beata Sieklucka, Marta Zieminska, Bogdan Cylwik, Dariusz Pawlak
Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401. International journal of molecular sciences 21 (17) (2020)

Krystyna Pawlak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Krystyna Pawlak